Nuformix (LSE:NFX) Interest Expense : £0.00 Mil (TTM As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nuformix's interest expense for the six months ended in Sep. 2022 was £ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2022 was £0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nuformix's Operating Income for the six months ended in Sep. 2022 was £ -0.42 Mil. Nuformix's Interest Expense for the six months ended in Sep. 2022 was £ 0.00 Mil. Nuformix has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Nuformix Interest Expense Historical Data

The historical data trend for Nuformix's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Interest Expense Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.03

-0.02

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Interest Expense	Get a 7-Day Free Trial									-	-	-	-	-

Nuformix Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Nuformix (LSE:NFX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nuformix's Interest Expense for the six months ended in Sep. 2022 was £0.00 Mil. Its Operating Income for the six months ended in Sep. 2022 was £-0.42 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Sep. 2022 was £0.00 Mil.

Nuformix's Interest Coverage for the quarter that ended in Sep. 2022 is calculated as

Nuformix had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.